RSS-Feed abonnieren

DOI: 10.1055/s-0045-1814728
Changes in Memory, Cognitive Function, and Pattern of Distress among Breast Cancer Patients and Survivors: A Study from a Tertiary Cancer Center
Autor*innen
Funding None.
Abstract
Introduction
Cancer-related cognitive impairment is an unexplored area, which can be distressing and can affect the daily functioning and quality of life of a cancer patient.
Objective
The aim of the study was to find the changes in memory, cognitive function, and pattern of distress among breast cancer patients and survivors using a cross-sectional comparative study design.
Materials and Methods
Women diagnosed with early breast cancer, aged between 20 and 60 years and planned for or those who underwent chemotherapy were included. Seventy-nine participants (survivors [N = 27], postchemotherapy patients [N = 27], and prechemotherapy patients [N = 25]) were assessed using the Post-Graduate Institute Memory Scale, Montreal Cognitive Assessment, National Comprehensive Cancer Network Distress Thermometer, and Distress Inventory for Cancer.
Results
Most of the survivors and postchemotherapy patients had increased cognitive (p = 0.02) and memory impairment (p = 0.057) than prechemotherapy patients. Memory was positively correlated with cognitive function (p = 0.000, r = 0.669) and negatively correlated with distress (p = 0.045, r = –0.226). Memory (p < 0.001) and cognitive functioning (p = 0.002) were better with higher education levels. Older participants had higher memory impairment (p = 0.05, r = –0.218).
Conclusion
The study concluded that there was cognitive decline and distress among breast cancer patients and survivors after completion of chemotherapy. Thus, the study highlights the importance of psychotherapeutic interventions to prevent and manage changes in memory, cognitive decline, and distress among breast cancer patients and survivors.
Authors' Contributions
N.J.: Conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, writing-original draft, and writing-review and editing.
J.A.: Conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, supervision, writing-original draft, and writing-review and editing.
S.V.K.: Conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, supervision, writing-original draft, and writing-review and editing.
P.K.S.V.P.: Conceptualization, project administration, resources, writing-original draft, and writing-review and editing.
R.K.: Formal analysis, methodology, writing-original draft, and writing-review and editing.
S.B.: Conceptualization, project administration, resources, and writing-review and editing.
G.M.: Project administration, resources, and writing-review and editing.
A.R.G.: Project administration, resources, and writing-review and editing.
Publikationsverlauf
Artikel online veröffentlicht:
04. Januar 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Breast cancer statistics and resources. Breast Cancer Research Foundation. January 17, 2025 . Accessed September 1, 2025 at: https://www.bcrf.org/breast-cancer-statistics-and-resources/
- 2 Chemotherapy for breast cancer. Cancer.org. Accessed September 1, 2025 at: https://www.cancer.org/cancer/types/breast-cancer/treatment/chemotherapy-for-breast-cancer.html
- 3 Jivani A, Shinde RK. A comprehensive review of taxane treatment in breast cancer: clinical perspectives and toxicity profiles. Cureus 2024; 16 (04) e59266
- 4 Sun H, Lv H, Zeng H, Niu L, Yan M. Distress Thermometer in breast cancer: systematic review and meta-analysis. BMJ Support Palliat Care 2022; 12 (03) 245-252
- 5 Kant J, Czisch A, Schott S, Siewerdt-Werner D, Birkenfeld F, Keller M. Identifying and predicting distinct distress trajectories following a breast cancer diagnosis - from treatment into early survival. J Psychosom Res 2018; 115: 6-13
- 6 Ar S, Nz Z. Anxiety, depression and coping strategies in breast cancer patients on chemotherapy. Chemother Malaysian J Psychiat 2010; 19 (02) 21-26
- 7 Boscher C, Joly F, Clarisse B. et al. Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors. Cancers (Basel) 2020; 12 (10) 3000
- 8 Seliktar N, Polek C, Brooks A, Hardie T. Cognition in breast cancer survivors: hormones versus depression. Psychooncology 2015; 24 (04) 402-407
- 9 Oldacres L, Hegarty J, O'Regan P, Murphy-Coakley NM, Saab MM. Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: a systematic review. Psychooncology 2023; 32 (02) 214-228
- 10 Schmidt ME, Goldschmidt S, Hermann S, Steindorf K. Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer 2022; 151 (08) 1280-1290
- 11 Pershad D, Wig NN. A battery of simple tests of memory for use in India. Neurol India 1976; 24 (02) 86-93
- 12 Julayanont P, Nasreddine ZS. Montreal cognitive assessment (MoCA): Concept and clinical review. In: Larner AJ. Cognitive Screening Instruments: A Practical Approach. Liverpool: Springer International Publishing; 2017: 139-195
- 13 Riba MB, Donovan KA, Andersen B. et al. Distress Management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17 (10) 1229-1249
- 14 Thomas BC, Mohan VN, Thomas I, Pandey M. Development of a distress inventory for cancer: preliminary results. J Postgrad Med 2002; 48 (01) 16-20
- 15 Ahles TA, Saykin AJ, McDonald BC. et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008; 110 (01) 143-152
- 16 Sharma D, Dutta M, Kaur S, Singh Yadav B, Kumar K, Dahiya D. Assessment of chemo fog among breast cancer survivors: a pilot study. Nurs Midwifery Res J 2021;
- 17 Hedayati E, Alinaghizadeh H, Schedin A, Nyman H, Albertsson M. Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs 2012; 16 (03) 315-322
- 18 Sekeres MJ, Bradley-Garcia M, Martinez-Canabal A, Winocur G. Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions. Int J Mol Sci 2021; 22 (23) 12697
- 19 Lange M, Heutte N, Noal S. et al. Cognitive changes after adjuvant treatment in older adults with early-stage breast cancer. Oncologist 2019; 24 (01) 62-68
- 20 Vayyat S, Revand R, Rastogi S, Sharma R, Kaur S. Patient-reported cognitive impairments and objective neuropsychological deficits in young sarcoma patients undergoing chemotherapy and its comparison to healthy controls: a tertiary health care study from India. Int J Cancer 2024; 154 (08) 1413-1422
- 21 Zhou W, Tian W, Xia J. et al. Alterations in degree centrality and cognitive function in breast cancer patients after chemotherapy. Brain Imaging Behav 2022; 16 (05) 2248-2257
- 22 Syed Alwi SM, Narayanan V, Mohd Taib NA, Che Din N. Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia. J Clin Exp Neuropsychol 2021; 43 (05) 534-545
- 23 Chen X, Li J, Ren J. et al. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psychooncology 2014; 23 (10) 1165-1171
- 24 de Ruiter MB, Reneman L, Boogerd W. et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 2011; 32 (08) 1206-1219
- 25 McDonald BC, Saykin AJ. Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations. Brain Imaging Behav 2013; 7 (04) 374-387
- 26 Lacourt TE, Koncz Z, Tullos EA, Tripathy D. A detailed description of the distress trajectory from pre- to post-treatment in breast cancer patients receiving neoadjuvant chemotherapy. Breast Cancer Res Treat 2023; 197 (02) 299-305
- 27 Neerukonda AR, Stevens MM, Reagan L. et al. Assesment of distress among breast cancer survivors. J Clin Oncol 2015; 33 (15) e12610-e12610
- 28 Oh GH, Yeom CW, Shim EJ. et al. The effect of perceived social support on chemotherapy-related symptoms in patients with breast cancer: a prospective observational study. J Psychosom Res 2020; 130 (109911): 109911
- 29 Syrowatka A, Motulsky A, Kurteva S. et al. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 2017; 165 (02) 229-245
- 30 Phoosuwan N, Lundberg PC. Psychological distress and health-related quality of life among women with breast cancer: a descriptive cross-sectional study. Support Care Cancer 2022; 30 (04) 3177-3186
- 31 Johnson MK, McMahon RP, Robinson BM. et al. The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia. Neuropsychology 2013; 27 (02) 220-229
- 32 Cordova MJ, Riba MB, Spiegel D. Post-traumatic stress disorder and cancer. Lancet Psychiatry 2017; 4 (04) 330-338
- 33 Kaiser J, Dietrich J, Amiri M. et al. Cognitive performance and psychological distress in breast cancer patients at disease onset. Front Psychol 2019; 10: 2584
- 34 Gan C, Yao S, Zhao J. et al. Expression of inflammatory states in response to psychological distress in breast cancer survivors and its relationship to subjective memory function complaints. BMC Womens Health 2025; 25 (01) 140
- 35 Chen D, Mackenzie L, Hossain SZ. et al. Cognitive impairment experienced by Chinese breast cancer survivors. Sci Rep 2023; 13 (01) 22245
- 36 Oliva G, Giustiniani A, Danesin L, Burgio F, Arcara G, Conte P. Cognitive impairment following breast cancer treatments: an umbrella review. Oncologist 2024; 29 (07) e848-e863
- 37 Crouch A, Champion V, Von Ah D. Cognitive dysfunction in older breast cancer survivors: an integrative review. Cancer Nurs 2022; 45 (01) E162-E178
- 38 Randhawa SS, Varghese D. Geriatric evaluation and treatment of age related cognitive decline. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. . Accessed on August 20, 2025 at: https://www.ncbi.nlm.nih.gov/books/NBK580536/
- 39 Levkovich I, Cohen M, Alon S. et al. Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: the mediating role of subjective stress. J Geriatr Oncol 2018; 9 (05) 469-475
- 40 Luo J, Schousboe JT, Ensrud KE, Hendryx M. Long-term changes of cognitive impairment among older breast cancer survivors. J Cancer Surviv 2023; 17 (06) 1760-1768
- 41 Phillips NS, Stratton KL, Williams AM. et al. Late-onset cognitive impairment and modifiable risk factors in adult childhood cancer survivors. JAMA Netw Open 2023; 6 (05) e2316077
- 42 Perrier J, Viard A, Levy C. et al. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level. Brain Imaging Behav 2020; 14 (01) 226-241
